News
12-17-2010, 05:30 AM
DiaGenic ASA and Pfizer Inc today signed an agreement for explorative R&D collaboration to identify biomarkers in early stages of Alzheimer's disease (AD) using DiaGenic's patented gene expression technology and its blood samples from ongoing clinical studies.
More... (http://www.news-medical.net/news/20101217/Diagenic-Pfizer-enter-collaboration-to-identify-biomarkers-in-early-stages-of-Alzheimers-disease.aspx)
More... (http://www.news-medical.net/news/20101217/Diagenic-Pfizer-enter-collaboration-to-identify-biomarkers-in-early-stages-of-Alzheimers-disease.aspx)